Incidence and Predictive Factors for Cytomegalovirus Infection in Renal Transplant Recipients

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2412-2415

  Corona Nakamura, A L ^a   Monteon Ramos F J ^a   Troyo Sanroman R ^b   Arias Merino, M J ^a   Anaya Prado, R ^c  

^a Specialities Hospital   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c School of Medicine University of Guadalajara ^*  (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; FEVER; GRAFT RECIPIENT; HUMAN; INCIDENCE; INFECTION RATE; KIDNEY TRANSPLANTATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEXICO; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; FEVER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROBABILITY; RISK; ROC CURVE; YOUNG ADULT;

EID: 69149083872     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.05.008     Document Type: Article

References (23)

1. Paya C.V., and Razonable R.R. Cytomegalovirus infection after solid organ transplantation. In: Bowden R.A., Ljungman P., and Paya C.V. (Eds). Transplant Infections. 2nd Ed. (2003), Lippincott-Raven Publishers, Philadelphia 298
2. Rowshani A.T., Bemelman F.J., van Leeuwen E.M., et al. Clinical and Immunologic Aspects of Cytomegalovirus Infection in Solid Organ Transplant Recipients. Transplantation 79 (2005) 381
3. Crumpacker C.S. Cytomegalovirus. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases. 5th Ed. (2000), Churchill Livingstone, Philadelphia 1586
4. Parra I.H., Franco M., Galimberti G., et al. Infección cutánea por citomegalovirus en un paciente trasplantado renal. Dermatol Argent 11 (2005) 277
5. Torre-Cisneros J., Fortún J., and Aguado J.M. Recomendaciones GESITRA-SEIMC y RESITRA sobre prevención y tratamiento de la infección por citomegalovirus e pacientes trasplantados. Enferm Infecc Microbiol Clin 23 (2005) 424
6. Pescovitz M.D. Review of the CMV in renal transplantation. Saudi J Kidney Dis Transplant 18 (2007) 505
7. Seale H., Dwyer D.E., and Chapman J.R. Cytomegalovirus disease amongst renal transplant recipients in Australia and New Zealand. Virol Res Treatment 1 (2008) 65
8. Brennan D.C. Cytomegalovirus in renal transplantation. J Am Soc Nephrol 12 (2001) 848
9. Fishman J.A., and Kotton C.N. Viral infection in the renal transplant recipient. J Am Soc Nephrol 16 (2005) 1758
10. Ricart Ma J., Malaise J., Moreno A., et al. Cytomegalovirus: ocurrence, severity and effect on graft survival in simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 20 suppl 2 (2005) ii25
11. Kuypers D.R.J., Claes K., Evenepoel P., et al. A simplified strategy for clinical management of late cytomegalovirus infection after oral ganciclovir prophylaxis in renal recipients. J Antimicrob Chemother 55 (2005) 391
12. Vozarova L., Huckova D., Noskovicova M., et al. Clinical study. The occurrence of symptomatic CMV infections in heart transplant recipients. Bratisl Lek Listy 104 (2003) 317
13. Sia I.G., and Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 13 (2000) 83
14. Heemann U., and Wenzel R.R. CMV prophylaxis: what is valid in 2002?. Nephrol Dial Transplant 17 (2002) 556
15. Nichols W.G., and Boeckh M. Cytomegalovirus infections. Current Treatment Options Infectious Dis 3 (2001) 78
16. Weinberg A., Schissel D., and Giller R. Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients. J Clin Microbiol 40 (2002) 4203
17. Leruez-Ville M., Ouachee M., Delarue R., et al. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J Clin Microbiol 41 (2003) 2040
18. Gómez E., Laurés S., Melón S., et al. Late CMV disease and/or recurrence in renal transplants recipients with prolonged oral ganciclovir prophylaxis. Transplantationsmedizin 15 (2003) S1
19. Bordils A., Molina J.M., Córdoba J., et al. Original. Carga viral y antigenemia de citomegalovirus en la monitorización de la profilaxis con valganciclovir en pacientes con trasplante renal. Rev Esp Quimioterap 18 (2005) 226
20. Preiser W., Rabenau H.F., Vogel J.U., et al. Performance characteristics of an automated PCR assay for the quantification of cytomegalovirus DNA in plasma. J Virol Methods 101 (2002) 149
21. Arias Rodríguez M. Epidemiología y manifestaciones clínicas de la infección por CMV en el trasplante renal. En: Aula Sobre Trasplantes de Órganos Sólidos. Hospital Universitario Marqués de Valdecilla, Santander. Drug Farma Roche. III edición, 2003
22. Hibberd P.L., and Snydman D.R. Cytomegalovirus infection in organ transplant recipients. In: Rubin R., and Moellering R.C. (Eds). Infectious Disease Clinics of North American. Infection in Transplantation (1995), W.B. Saunders Company, Philadelphia 863 December 1995
23. Costa S.C.B., Miranda S.R.P., Alves G., et al. Detection of cytomegalovirus infections by PCR in renal transplant patients. Braz J Med Biol Res 32 (1999) 953